Gene:
GSTP1
glutathione S-transferase pi 1

PharmGKB contains no dosing guidelines for this gene. To report known dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this gene. To report a drug label with PGx, click here.

PharmGKB contains no Clinical Variants that meet the highest level of criteria.

To see more Clinical Variants with lower levels of criteria, click the button at the bottom of the table.

Position ? Drug ? Relevance ? Strength of
Evidence ?
rs1695 2
rs1695 more likely to cause hematological toxicity 2
rs1138272 dose difficult to predict 2
rs1695 more likely to cause neurotoxicity 3
rs1695 less likely to work 3

Download a summary of all Clinical Annotations available.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

PharmGKB contains no genetic tests for this gene. To report genetic tests, click here.

The table below contains information about pharmacogenomic variants on PharmGKB. Please follow the link in the "Variant" column for more information about a particular variant. Each link in the "Variant" column leads to the corresponding PharmGKB Variant Page. The Variant Page contains summary data, including PharmGKB manually curated information about variant-drug pairs based on individual PubMed publications. The PMIDs for these PubMed publications can be found on the Variant Page.

The tags in the first column of the table indicate what type of information can be found on the corresponding Variant Page.

Links in the "Drugs" column lead to PharmGKB Drug Pages.

Variant?
(build 132)
Alternate Names ? Drugs ? Alleles ? Function ? Amino Acid?
Translation
rs1138272 A114V, GSTP1: A114V, GSTP1: C341T, c.341C>T, g.12659374C>T, g.7514C>T, p.Ala114Val C > T Missense Ala114Val
rs1695 GSTP1*2, GSTP1*B, GSTP1: I105V, GSTP1:A313G, GSTP1:I105V, GSTP1:Ile105Val, Part of haplotypes GSTP1*B and GSTP1*C, c.313A>G, g.12658484A>G, g.6624A>G, p.Ile105Val, rs1695:A>G A > G Missense Ile105Val
Alleles, Functions, and Amino Acid Translations are all sourced from dbSNP build 132

Overview

Alternate Names:  GST class-pi; GSTP1-1; OTTHUMP00000174659; deafness, X-linked 7; fatty acid ethyl ester synthase III; glutathione S-transferase P; glutathione S-transferase pi; glutathione transferase
Alternate Symbols:  DFN7; FAEES3; GST3; GSTP; PI
PharmGKB Accession Id: PA29028

Details

Cytogenetic Location: chr11 : q13.2 - q13.2
GP mRNA Boundary: chr11 : 67351066 - 67354124
GP Gene Boundary: chr11 : 67341066 - 67357124
Strand: plus
Product Name: deafness, X-linked 7, fatty acid ethyl ester synthase III, glutathione transferase
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

PharmGKB Curated Pathways

Pathways created internally by PharmGKB based primarily on literature evidence.

  1. Platinum Pathway
    Representation of the candidate genes involved in the metabolism of platinum containing drugs.

External Pathways

Links to non-PharmGKB pathways.

  1. multi-drug resistance factors - (BioCarta via Pathway Interaction Database)

Curated Information ?

Gene Relationship Evidence
GSTM1
  •   
  •   
Publications
GSTM3
  •   
  •   
Publications

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other genes is available.

Curated Information ?

Drug Class Relationship Evidence
antimetabolites
  •   
  •   
Publications
antineoplastic agents
  • PD
  •   
Publications
folic acid analogues
  •   
  •   
Publications
Platinum compounds
  • PD
  • PK
Publications
podophyllotoxin derivatives
  •   
  •   
Publications
Pyrimidine analogues
  • PD
  •   
Publications
taxanes
  •   
  •   
Publications
topoisomerase I inhibitors
  •   
  •   
Publications
vinca alkaloids and analogues
  •   
  •   
Publications
xenobiotics
  •   
  • PK
Publications

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other drugs is available.

Curated Information ?

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other diseases is available.

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.